Accelerating Lentivirus Manufacturing: Choosing The Right Plasmid Manufacturing Platform
On-Demand Webinar
Watch this webinar from Philippe Ledent, Chief Scientific Director at Xpress Biologics, now part of Sartorius and Rakel Lopez de Maturana, Qualified Person & Regulatory Affairs Director at VIVEbiotech discuss how to ensure gain of time and success of lentiviral-based therapies from process development up to market approval.
What You Will Learn:
- Meeting regulatory compliance for plasmids used for lentivirus manufacturing
- Ensuring same manufacturing process and specifications for research to GMP grade plasmid manufacturing
- Adaptable plasmid manufacturing platform is critical to accelerate lentivirus manufacturing